DVA

$149.98

Post-MarketAs of Mar 17, 8:00 PM UTC

DaVita Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$149.98
Potential Upside
96.6%
Whystock Fair Value$294.83
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpa...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.03B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
15.75
Beta
Defensive asset. Lower volatility than the S&P 500.
0.93
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
64.85%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.17

Recent News

Zacks
Mar 17, 2026

4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts

An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 17, 2026

Zacks.com featured highlights include Strategic Education, Seanergy Maritime Holdings, DaVita and FirstEnergy

Strategic Education and peers near 52-week highs show strong momentum, backed by earnings growth, strategic expansion and solid outlooks.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 16, 2026

4 Stocks Trading Near 52-Week Highs With Room to Rise Further

Investors target stocks that have been on a bullish run. Stocks like STRA, SHIP, DVA and FE are seeing price strength, and the momentum is likely to continue.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 14, 2026

3 No-Brainer Warren Buffett Stocks to Buy Right Now

Back up the truck with these Warren Buffett stocks

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Mar 12, 2026

Quest Diagnostics (DGX) Down 4.2% Since Last Earnings Report: Can It Rebound?

Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.